Eva Pérez‐Pampín

Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

J.V. Pérez-Moreiras, Juan J. Gómez‐Reino, José Ramón Maneiro et al. · American Journal of Ophthalmology · 2018 · 277 citations

Medicine, Randomized Clinical Trial, Dermatology

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

Loreto Carmona, M.Á. Descalzo, Eva Pérez‐Pampín et al. · Annals of the Rheumatic Diseases · 2007 · 228 citations · Full text

Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate

María C. de Andrés, Eva Pérez‐Pampín, Manuel Calaza et al. · Arthritis Research & Therapy · 2015 · 144 citations · Full text

Rheumatoid Disorder, Rheumatology, Chromatin +13

Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients

J. Loricera, Ricardo Blanco, José L. Hernández et al. · Seminars in Arthritis and Rheumatism · 2014 · 132 citations · Full text

Rheumatology, Autoimmune Disease, Vasculitis +6

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 105 citations · Full text

Rheumatology, Autoimmune Disease, Vasculitis +6